» Articles » PMID: 25620723

Variation in Tobacco and Mainstream Smoke Toxicant Yields from Selected Commercial Cigarette Products

Overview
Publisher Elsevier
Specialties Pharmacology
Toxicology
Date 2015 Jan 27
PMID 25620723
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

There is a drive toward the mandated lowering and reporting of selected toxicants in tobacco smoke. Several studies have quantified the mainstream cigarette emissions of toxicants, providing benchmark levels. Few, however, have examined how measured toxicant levels within a single product vary over time due to natural variation in the tobacco, manufacturing and measurement. In a single centre analysis, key toxicants were measured in the tobacco blend and smoke of 3R4F reference cigarette and three commercial products, each sampled monthly for 10 months. For most analytes, monthly variation was low (coefficient of variation <15%); but higher (⩾ 20%) for some compounds present at low (ppb) levels. Reporting toxicant emissions as a ratio to nicotine increased the monthly variation of the 9 analytes proposed for mandated lowering, by 1-2 percentage points. Variation in toxicant levels was generally 1.5-1.7-fold higher in commercial cigarettes compared with 3R4F over the 10-month period, but increased up to 3.5-fold for analytes measured at ppb level. The potential error (2CV) associated with single-point-in-time sampling averaged ∼ 20%. Together, these data demonstrate that measurement of emissions from commercial cigarettes is associated with considerable variation for low-level toxicants. This variation would increase if the analyses were conducted in more than one laboratory.

Citing Articles

Determination of Humectants in Tobacco Filler by High Performance Chromatography/Single Quadrupole Mass Spectrometry.

Xizheng Y, Valentin-Blasini L, Watson C, Cardenas R Beitr Tab Int. 2024; 28(4):170-178.

PMID: 38854422 PMC: 11160111. DOI: 10.2478/cttr-2018-0016.


Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets.

Wang L, Koelink P, Garssen J, Folkerts G, Henricks P, Braber S Int J Mol Sci. 2024; 25(7).

PMID: 38612871 PMC: 11012690. DOI: 10.3390/ijms25074058.


Quantitation by Liquid Chromatography-Nanoelectrospray Ionization-High-Resolution Tandem Mass Spectrometry of Multiple DNA Adducts Related to Cigarette Smoking in Oral Cells in the Shanghai Cohort Study.

Cheng G, Guo J, Wang R, Yuan J, Balbo S, Hecht S Chem Res Toxicol. 2023; 36(2):305-312.

PMID: 36719849 PMC: 10148603. DOI: 10.1021/acs.chemrestox.2c00393.


Carbonyl Yields in Cigars under Three Smoking Regimens Using a Linear Smoking Machine.

Young M, Feng C, Cecil T, Johnson T Chem Res Toxicol. 2023; 36(1):94-103.

PMID: 36602460 PMC: 9846831. DOI: 10.1021/acs.chemrestox.2c00322.


Changes in intestinal homeostasis and immunity in a cigarette smoke- and LPS-induced murine model for COPD: the lung-gut axis.

Wang L, Pelgrim C, Peralta Marzal L, Korver S, Van Ark I, Leusink-Muis T Am J Physiol Lung Cell Mol Physiol. 2022; 323(3):L266-L280.

PMID: 35699290 PMC: 9423728. DOI: 10.1152/ajplung.00486.2021.